Free Trial

ENDRA Life Sciences (NDRA) Earnings Date, Estimates & Call Transcripts

ENDRA Life Sciences logo
$3.67 +0.32 (+9.55%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$3.50 -0.18 (-4.77%)
As of 04/17/2025 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENDRA Life Sciences Earnings Summary

Upcoming
Earnings Date
May. 13Before Market OpensEstimated
Consensus EPS
(Mar. 31)
-$4.10
Actual EPS
(Mar. 31)
-$9.40 Missed By -$5.30

ENDRA Life Sciences announced Q4 2024 earnings on March 31, 2025, reporting an EPS of -$9.40, which missed the consensus estimate of -$4.10 by $5.30. With a trailing EPS of -$624.72, ENDRA Life Sciences' earnings are expected to grow next year, from ($47.46) to ($15.38) per share.

Q4 2024 Earnings Resources

NDRA Upcoming Earnings

ENDRA Life Sciences' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ENDRA Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NDRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENDRA Life Sciences Analyst EPS Estimates

Current Year EPS Consensus Estimate
($47.46) EPS
Next Year EPS Consensus Estimate
($15.38) EPS

ENDRA Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
-------
3/31/2025Q4 2024-$4.10-$9.40 -$5.30-$20.78--
8/14/2024Q2 2024-$122.50-$140.00 -$17.50-$0.08--
5/14/2024Q1 2024--$22,750.00 -$22,750.00-$0.26--
3/28/2024Q4 2023--$14,875.00 -$14,875.00-$0.17--
11/14/2023Q3 2023--$700.00 -$700.00-$0.40--
8/14/2023Q2 2023--$752.50 -$752.50-$0.43--
5/15/2023Q1 2023-$1,785.00-$1,627.50+$157.50-$0.93--

ENDRA Life Sciences Earnings - Frequently Asked Questions

ENDRA Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on NDRA's earnings history.

In the previous quarter, ENDRA Life Sciences (NASDAQ:NDRA) missed the analysts' consensus estimate of ($4.10) by $5.30 with a reported earnings per share (EPS) of ($9.40). Learn more on analysts' earnings estimate vs. NDRA's actual earnings.

ENDRA Life Sciences (NASDAQ:NDRA) has a recorded net income of -$10.06 million. NDRA has generated -$624.72 earnings per share over the last four quarters.

ENDRA Life Sciences's earnings are expected to grow from ($47.46) per share to ($15.38) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NDRA) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners